Inspire Investing’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.17M Buy
25,177
+25,169
+314,613% +$2.26M 0.13% 189
2025
Q4
$698 Buy
+8
New +$607 ﹤0.01% 1038
2025
Q2
Sell
-10,476
Closed -$767K 846
2025
Q1
$767K Buy
+10,476
New +$866K 0.09% 215
2024
Q3
Sell
-5,115
Closed -$350K 861
2024
Q2
$350K Sell
5,115
-1,526
-23% -$91.2K 0.04% 655
2024
Q1
$356K Sell
6,641
-522
-7% -$28.1K 0.04% 727
2023
Q4
$382K Buy
7,163
+1,002
+16% +$48.8K 0.04% 736
2023
Q3
$306K Buy
6,161
+892
+17% +$49.9K 0.04% 678
2023
Q2
$314K Buy
5,269
+490
+10% +$27.9K 0.04% 615
2023
Q1
$271K Buy
4,779
+1,601
+50% +$103K 0.03% 754
2022
Q4
$236K Sell
3,178
-312
-9% -$21.2K 0.03% 475
2022
Q3
$208K Sell
3,490
-273
-7% -$16.4K 0.03% 387
2022
Q2
$211K Buy
3,763
+571
+18% +$37.5K 0.03% 659
2022
Q1
$236K Sell
3,192
-216
-6% -$15K 0.03% 494
2021
Q4
$246K Buy
3,408
+523
+18% +$38K 0.03% 700
2021
Q3
$221K Buy
+2,885
New +$232K 0.03% 753
2018
Q1
Sell
-1,450
Closed -$60K 391
2017
Q4
$60K Buy
+1,450
New +$50.8K 0.05% 304

Other funds holding GMED

Inspire Investing's GMED Position: Q1 2026 in Review

Inspire Investing increased its Globus Medical (GMED) stake by 314,613% in Q1 2026, buying an estimated $2.26M and bringing the position to 25,177 shares worth $2.17M. The position accounts for 0.13% of the portfolio, ranked #189.

Inspire Investing first reported a position in GMED in Q4 2017 and has held it in 16 quarters since. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Inspire Investing held 25,177 shares of Globus Medical worth $2.17M as of Q1 2026.
  • Inspire Investing bought 25,169 Globus Medical shares in Q1 2026, an estimated $2.26M.
  • Globus Medical made up 0.13% of Inspire Investing's portfolio in Q1 2026, its #189 holding.
  • Inspire Investing first reported a position in Globus Medical in Q4 2017 and has held it in 16 quarters since.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.